Thomas Seyfried, PhD

4 years ago
71

Thomas Seyfried, PhD discusses "Cancer as a Mitochondrial Disease: Implications for Novel Therapeutics" at the 2018 Spring Conference of the IAOMT in Denver, CO.

Presented at IAOMT's 2018 Spring Conference in Denver, CO.

Dr. Thomas N. Seyfried is Professor of Biology at Boston College, and received his Ph.D. in Genetics and Biochemistry from the University of Illinois. He also holds a Master's degree in Genetics from Illinois State University. He was a Postdoctoral Fellow in the Department of Neurology at the Yale University School of Medicine, and then served on the faculty as an Assistant Professor in Neurology. Dr. Seyfried previously served as Chair, Scientific Advisory Committee for the National Tay-Sachs and Allied Diseases Association, and he recently received a Lifetime Achievement Award for his work on cancer from the Academy of Complimentary and Integrative Medicine. He presently serves on several editorial boards, including those for Nutrition & Metabolism, Neurochemical Research, the Journal of Lipid Research, and ASN Neuro. Dr. Seyfried has over 180 peer-reviewed publications and is author of the book Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer (Wiley Press).

Disclaimer: The information provided on this video is not intended as medical advice and should not be interpreted as such. If you seek medical advice, please consult with a health care professional. Also, the information in this video represents the thoughts of the individual speaker/s, and the views expressed in this interview do not necessarily reflect the views of the IAOMT, its individual members, its Executive Committee, its Scientific Advisory Council, its administration, its employees, contractors, sponsors, or any other IAOMT affiliates.

Loading comments...